[AstraZeneca United States](https://www.astrazeneca-us.com)

Rolling (applications reviewed and approved on a rolling basis)

Not specified; varies by proposal scope and budget.

Supports independent medical education programs to raise awareness, improve diagnosis, and disseminate treatment knowledge about transthyretin amyloidosis for healthcare professionals.

Emphasis on certified education credits and multidisciplinary reach.

--- ## Description AstraZeneca United States invites proposals for independent medical education (IME/CME) grants focused on transthyretin amyloidosis, including hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) and mixed phenotype (ATTRv-CM with ATTRv-PN). The goal is to expand disease awareness, improve early recognition and diagnosis, and share current and emerging clinical data on ATTRv treatments. Educational initiatives should also address patient care planning and benefit a multidisciplinary audience of healthcare professionals. Programs may utilize diverse learning formats such as live or virtual sessions, enduring materials, podcasts, panel discussions, simulations, patient case studies, and print resources, with a strong emphasis on certified education credits. --- ## Due Dates - Applications are accepted and reviewed on a rolling basis. - Program anticipated start dates: February 1, 2026, through December 31, 2026. --- ## Funding Amount - Award size is not specified and will depend on the proposal's scope and budget. - Funding is determined based on the proposed education program and its potential impact. --- ## Eligibility - Open to educational providers capable of delivering high-standard independent medical education (IME/CME) programs. - Target audience includes: - Neurologists (neuromuscular and peripheral neuropathy) - Cardiologists (heart failure) - Geneticists - Primary Care Physicians - Nurses - Advanced Practice Providers - Pharmacists - Activities must be independent, educational, and focused on the specified disease areas. --- ## Application Process - Submit a formal letter of request and a detailed grant proposal including: - Needs assessment - Learning objectives - Agenda - Budget schedule - Proposals should be sent via email to [grants@astrazeneca.com](mailto:grants@astrazeneca.com). - For more information and submission, visit [AstraZeneca Grants Portal](https://www.astrazenecagrants.com). - Contact: Donna Maier, PhD, Associate Director, Medical Education and Grants Office ([donna.maier@astrazeneca.com](mailto:donna.maier@astrazeneca.com)). --- ## Additional Information - Programs should prioritize certified education credits for a multidisciplinary audience. - Recommended formats include live, virtual, enduring materials, podcasts, panel discussions, simulations, patient case studies, and print. - Proposals are evaluated based on educational need, innovation, and potential to improve patient care and outcomes. --- ## External Links - [AstraZeneca United States](https://www.astrazeneca-us.com) - [AstraZeneca Grants Portal](https://www.astrazenecagrants.com) - [RFP PDF: Full Program Details](https://www.astrazeneca-us.com/content/dam/az-us/Sustainability/PDF/CGA-Amyloidosis-2026.pdf) --- ## Contact Information | Name/Office | Email | Phone | |-----------------------------------------------|-----------------------------------------------|---------------| | Medical Education Grants Office (MEGO) | [grants@astrazeneca.com](mailto:grants@astrazeneca.com) | 800-456-3669 | | Donna Maier, PhD, Associate Director | [donna.maier@astrazeneca.com](mailto:donna.maier@astrazeneca.com) | |

Request for Proposal (RFP) for an Independent Medical Education Grant

Sign in to see full grant listing